Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T21:38:41.441Z.
Calculation as of: 2026-10-06T21:38:41.441Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 69c6abe1898d62982c9f5472fcc208679ef9964d1dbc89e7ebe68f1e3eabf120
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-11-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Protara Therapeutics, Inc.
Market Cap
$143.60M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$143.84M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.27M
EV/Sales Ratio
0.21x
TTM Avg
6.51x
3Y Avg
3.60x
5Y Avg
2.98x
Market Cap
$146.62M
EV/Sales Ratio
N/A
TTM Avg
408.01x
3Y Avg
408.01x
5Y Avg
408.01x
Market Cap
$139.84M
EV/Sales Ratio
2.11x
TTM Avg
2.70x
3Y Avg
2.25x
5Y Avg
3.83x
Market Cap
$139.47M
EV/Sales Ratio
6.43x
TTM Avg
9.42x
3Y Avg
15.43x
5Y Avg
15.43x
Market Cap
$139.04M
EV/Sales Ratio
N/A
TTM Avg
87090.85x
3Y Avg
33916.84x
5Y Avg
33916.84x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | $143.60M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 4.96x | 17.77x | 41.49x | 54.53x |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | 0.21x | 6.51x | 3.60x | 2.98x |
| Codexis, Inc. (CDXS)vs › | $146.28M | 2.47x | 3.21x | 3.47x | 4.66x |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | N/A | 408.01x | 408.01x | 408.01x |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | 2.11x | 2.70x | 2.25x | 3.83x |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | 6.43x | 9.42x | 15.43x | 15.43x |
| Immuneering Corporation (IMRX)vs › | $139.04M | N/A | 87090.85x | 33916.84x | 33916.84x |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2015-11-12 | 75.24x |
| 2015-11-11 | 76.29x |
| 2015-11-10 | 77.74x |
| 2015-11-09 | 76.85x |
| 2015-11-06 | 76.57x |
| 2015-11-05 | 76.29x |
| 2015-11-04 | 76.35x |
| 2015-11-03 | 74.51x |
| 2015-11-02 | 74.74x |
| 2015-10-30 | 70.51x |
| 2015-10-29 | 70.73x |
| 2015-10-28 | 71.12x |
| 2015-10-27 | 71.23x |
| 2015-10-26 | 74.24x |
| 2015-10-23 | 77.24x |
| 2015-10-22 | 86.53x |
| 2015-10-21 | 86.70x |
| 2015-10-20 | 86.25x |
| 2015-10-19 | 81.58x |
| 2015-10-16 | 78.91x |
| 2015-10-15 | 77.13x |
| 2015-10-14 | 74.35x |
| 2015-10-13 | 76.13x |
| 2015-10-12 | 75.24x |
| 2015-10-09 | 75.07x |
| 2015-10-08 | 73.40x |
| 2015-10-07 | 75.57x |
| 2015-10-06 | 72.85x |
| 2015-10-05 | 76.18x |
| 2015-10-02 | 72.73x |
| 2015-10-01 | 67.78x |
| 2015-09-30 | 71.68x |
| 2015-09-29 | 66.95x |
| 2015-09-28 | 64.33x |
| 2015-09-25 | 70.12x |
| 2015-09-24 | 75.52x |
| 2015-09-23 | 74.29x |
| 2015-09-22 | 74.90x |
| 2015-09-21 | 75.07x |
| 2015-09-18 | 77.46x |
| 2015-09-17 | 78.30x |
| 2015-09-16 | 77.85x |
| 2015-09-15 | 79.30x |
| 2015-09-14 | 77.69x |
| 2015-09-11 | 77.24x |
| 2015-09-10 | 76.18x |
| 2015-09-09 | 71.29x |
| 2015-09-08 | 71.34x |
| 2015-09-04 | 71.40x |
| 2015-09-03 | 71.73x |
| 2015-09-02 | 76.24x |
| 2015-09-01 | 72.57x |
| 2015-08-31 | 73.12x |
| 2015-08-28 | 73.74x |
| 2015-08-27 | 70.01x |
| 2015-08-26 | 71.18x |
| 2015-08-25 | 66.39x |
| 2015-08-24 | 67.95x |
| 2015-08-21 | 71.18x |
| 2015-08-20 | 68.73x |
| 2015-08-19 | 69.56x |
| 2015-08-18 | 69.56x |
| 2015-08-17 | 72.46x |
| 2015-08-14 | 67.89x |
